{"nctId":"NCT00124020","briefTitle":"Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus","startDateStruct":{"date":"2005-01"},"conditions":["Bacterial Pneumonia"],"count":771,"armGroups":[{"label":"Telavancin","type":"EXPERIMENTAL","interventionNames":["Drug: Telavancin"]},{"label":"Vancomycin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Vancomycin"]}],"interventions":[{"name":"Telavancin","otherNames":["TD6424","VIBATIV"]},{"name":"Vancomycin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Clinical signs and symptoms consistent with pneumonia acquired after at least 48 hours of continuous stay in an inpatient acute or chronic care facility or acquired within 7 days after being discharged from a hospitalization of greater than or equal to 3 days duration.\n\nExclusion Criteria:\n\n* Received more than 24 hours of potentially effective systemic (IV, IM or PO) antibiotic therapy for Gram-positive pneumonia immediately prior to randomization.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinical Response","description":"Clinical Response: Categorical (Cured, Failed or Indeterminate)\n\n* Failure - at least one of the following:\n* Persistence or progression of signs and symptoms of pneumonia that still require antibiotic therapy\n* Termination of study med due to \"lack of efficacy\"\n* Death on or after Day 3 attributable to primary infection\n* Cure: Signs and symptoms of pneumonia improved to the point that no further antibiotics for pneumonia were required, and baseline radiographic findings improved or did not progress.\n* Indeterminate: Inability to determine outcome","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"227","spread":null},{"groupId":"OG001","value":"228","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null},{"groupId":"OG001","value":"52","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"38","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":107,"n":379},"commonTop":["Diarrhoea","Constipation","Anemia","Hypokalemia","Hypotension"]}}}